Jeanette W. Loeb
About Jeanette W. Loeb
Jeanette W. Loeb (age 72) is an Independent Director of AllianceBernstein Global High Income Fund, Inc. (AWF), serving since April 2020; she is a Class Three Director with a term expiring at the 2027 annual meeting. She is Chair of the Governance and Nominating Committee (since August 2023) and a member of the Audit Committee and Independent Directors Committee; she also serves as Chair of the Governance and Nominating Committees across the AB Funds Complex since January 2025 . Her background includes serving as CEO of PetCareRx (2002–2011; 2015–April 2023), Partner at Goldman Sachs (1986–1994), director of AB Multi-Manager Alternative Fund (2012–2018), and director of MidCap Financial Investment Corporation (2011–July 2023); she is also a long-serving director of New York City Center (since 2005) .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| PetCareRx (e-commerce pet pharmacy) | Chief Executive Officer | 2002–2011; 2015–Apr 2023 | Led private e-commerce business |
| Goldman Sachs Group, Inc. | Partner; prior roles since 1977 | Partner 1986–1994 | Senior financial services leadership |
| AB Multi-Manager Alternative Fund (AMMAF) | Director | 2012–2018 | Governance of fund-of-hedge-funds |
| MidCap Financial Investment Corporation (public BDC) | Director (audit committee member noted) | Aug 2011–Jul 2023 | Board service; audit committee experience |
| United Nations Development Corporation (non-profit) | Director/Trustee | Not specified | Non-profit board governance |
| New York City Center (non-profit) | Director | Since 2005 | Arts institution governance |
External Roles
| Organization | Role | Current/Recent | Notes |
|---|---|---|---|
| AB Funds Complex | Chair, Governance & Nominating Committees | Since Jan 2025 | Oversees governance standards across 95 portfolios |
| Public company boards | None | Current: None | No current public company directorships disclosed |
| New York City Center | Director | Ongoing (since 2005) | Non-profit board service |
Board Governance
- Committee memberships: Audit; Governance & Nominating (Chair); Independent Directors Committee (all composed exclusively of Independent Directors) .
- Independence: Loeb is an Independent Director; the Board is led by an Independent Chair (Garry L. Moody) and Independent Directors meet in executive session at every Board meeting .
- Tenure and service: Director since April 2020; “Years of Service” 5 as of the 2025 meeting; oversees 95 portfolios in the AB Funds Complex .
- Meeting cadence and engagement: In fiscal 2024, AGHIF Board met 4 times; ANMIF Board met 4 times. Audit Committee met 4 times (AGHIF) and 3 times (ANMIF); Governance & Nominating met 3 times (each Fund); Independent Directors Committee met 9 times (each Fund). Governance & Nominating Committee annually reviews each Director’s performance including attendance and preparation .
| Committee/Board Meetings | AGHIF FY2024 | ANMIF FY2024 |
|---|---|---|
| Board | 4 | 4 |
| Audit Committee | 4 | 3 |
| Governance & Nominating | 3 | 3 |
| Independent Directors Committee | 9 | 9 |
- Structure and investor protections: Classified Board (three classes, staggered terms) which may be viewed as an anti-takeover provision; Independent Director serves as Chair per governance settlements; independent legal counsel engaged for Independent Directors .
Fixed Compensation
Directors of the Funds and the AB Funds Complex are compensated in cash; no pension/retirement benefits are provided (2024 exception for a one-time retirement benefit for two former SCB/AMMAF directors paid via Adviser fee waiver; not applicable to Loeb). No equity awards or option grants are disclosed in the proxy tables .
| Metric (USD) | 2023 | 2024 |
|---|---|---|
| AGHIF – Cash compensation | $3,820 | $4,024 |
| ANMIF – Cash compensation | $2,760 | $3,331 |
| AB Funds Complex – Total director compensation | $350,625 | $437,000 |
| Investment companies overseen (count) | 28 | 28 |
| Investment portfolios overseen (count) | 82 | 95 |
Notes:
- “Board Compensation” sections state neither Fund pays fees to directors when they are “interested persons” and outline aggregate complex-wide compensation; no equity instruments disclosed for directors .
Performance Compensation
- No performance-based elements (bonuses, PSUs/RSUs tied to TSR/EBITDA, options) are disclosed for Independent Directors; proxy tables list fixed cash amounts only, with no equity or incentive metrics provided for directors .
| Performance Metric | 2023 | 2024 |
|---|---|---|
| Target bonus % / actual bonus | Not disclosed | Not disclosed |
| Stock awards (RSUs/PSUs) | Not disclosed (no awards shown in director tables) | Not disclosed (no awards shown in director tables) |
| Option awards | Not disclosed | Not disclosed |
| Performance metrics (TSR/EBITDA/ESG) | Not disclosed | Not disclosed |
| Clawbacks / COI provisions | Not disclosed for directors | Not disclosed for directors |
Other Directorships & Interlocks
| Company/Organization | Type | Role | Dates |
|---|---|---|---|
| MidCap Financial Investment Corporation (MFIC) | Public BDC | Director (audit committee experience noted) | Aug 2011–Jul 2023 |
| AB Multi-Manager Alternative Fund | Registered fund | Director | 2012–2018 |
| New York City Center | Non-profit | Director | Since 2005 |
| United Nations Development Corporation | Non-profit | Director/Trustee | Not specified |
- Current public company directorships: None disclosed; “Other Directorships Currently Held” for Loeb shows “None” in 2025 proxy .
Expertise & Qualifications
- Financial services executive experience (former Goldman Sachs partner); operating leadership (CEO of PetCareRx); fund governance leadership (Chair of Governance & Nominating Committees); audit committee experience at a public BDC; extensive non-profit board service (NYC Center; UN Development Corporation) .
Equity Ownership
- Ownership alignment: Dollar ranges indicate personal investment in AWF and ANMIF; directors and officers as a group own less than 1% of each Fund’s shares.
| Metric | 2023 | 2024 |
|---|---|---|
| AGHIF – Dollar range owned (Loeb) | $10,001–$50,000 | $10,001–$50,000 |
| ANMIF – Dollar range owned (Loeb) | $10,001–$50,000 | $10,001–$50,000 |
| Aggregate dollar range across AB Funds Complex | Over $100,000 | Over $100,000 |
| Directors/officers group ownership (% of shares) | <1% (each Fund) | <1% (each Fund) |
- Shares pledged/hedged: Not disclosed for Loeb; no pledging or hedging noted in proxy .
- Ownership guidelines: Not disclosed for directors .
Insider Trades
| Item | Status | Notes |
|---|---|---|
| Section 16(a) compliance (FY2023 proxy view) | Compliant for directors | Funds believe all required filings were made; one late Form 3 was filed for Controller Phyllis J. Clarke (not a director) . |
| Reported Form 4 transactions | Not disclosed in proxy | No director Form 4 transactions listed in proxy materials . |
Governance Assessment
- Strengths:
- Independent status with leadership as Chair of Governance & Nominating; membership across key committees enhances board oversight and succession/governance processes .
- Documented audit committee experience at a public BDC; deep financial services and operating background; active non-profit governance .
- Regular executive sessions of Independent Directors; independent Board Chair; committees solely composed of Independent Directors support objective oversight .
- Potential concerns / red flags to monitor:
- Classified board structure can entrench incumbents and reduce investor agility in reshaping the board during governance disputes .
- Attendance rates by individual directors are not disclosed; while governance processes include annual performance reviews (including attendance), investors do not have person-level attendance transparency .
- Complex-wide director compensation increased year-over-year ($350,625 → $437,000) as portfolios overseen expanded (82 → 95), which may raise time-allocation scrutiny for multi-fund oversight; however, this is typical of unitary board structures in large complexes .
- Conflicts/related party transactions:
- No related-party transactions involving Loeb are disclosed; the Adviser is an affiliate of the Funds, but committee structures and independent leadership are designed to mitigate conflicts .